Daiwa analyst Narumi Nakagiri upgraded Pfizer to Outperform from Neutral with a $51 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
Daiwa analyst Narumi Nakagiri upgraded Pfizer to Outperform from Neutral with a $51 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PFE: